ClinicalTrials.gg

Program

SGC001

A development code. Also written as “SGC001 injection”.

Its studies are mostly in Anterior Wall Myocardial Infarction · Pancreatitis · ST Elevation Myocardial Infarction, led by Beijing Sungen Biomedical Technology.

Furthest: phase 2, since Dec 24, 20254 company-led studies, 2 open or runningNext primary completion: Apr 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Beijing Sungen Biomedical Technology42 open or runningphase 2since Dec 24, 2025Jun 24, 2025Apr 2027phase 2 · NCT07306182

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 24, 2025First studies: 2 phase 1 studies in Anterior Wall Myocardial InfarctionFirst studyNCT07091929, NCT07079618
  2. Dec 24, 2025Phase 2 study in ST Elevation Myocardial InfarctionPhase 2 reachedNCT07306182 · 210 planned · China
  3. Aug 25, 2026Phase 2 study in PancreatitisNCT07803965 · 129 planned · China

Ahead

  1. Apr 2027Primary completion: phase 2 study in ST Elevation Myocardial InfarctionNCT07306182
  2. Nov 2027Primary completion: phase 2 study in PancreatitisNCT07803965

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07803965Pancreatitis · China2RecruitingNov 2027129
NCT07306182ST Elevation Myocardial Infarction · China2RecruitingApr 2027210
NCT07091929Anterior Wall Myocardial Infarction · China1CompletedJul 18, 202538
NCT07079618Anterior Wall Myocardial Infarction · China1CompletedJul 15, 202549

How it is read

Names in the registry

  • “SGC001 injection”, 3 entries
  • “SGC001”, 2 entries

Codes read as this program: SGC001.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.